Deal Watch: Lilly/Qiagen Tie-Up Leads Spate Of Cancer Diagnostic Partnerships
Executive Summary
Bayer looks to augment Xofigo and its prostate cancer portfolio through development and commercialization pact with Orion around Phase III-ready asset once partnered with Endo. Meanwhile, Shire and arGEN-X expand a collaboration in which the latter’s antibody-discovery technologies are being used to discover potential candidates against targets chosen by Shire.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.